ISRCTN ISRCTN97145188
DOI https://doi.org/10.1186/ISRCTN97145188
Protocol serial number Dutch Cancer Society 2001-2379; NTR63
Sponsor Dutch Cancer Society (The Netherlands)
Funder Dutch Cancer Society
Submission date
12/09/2005
Registration date
12/09/2005
Last edited
28/11/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr PFM Stalmeier
Scientific

Radboud University Nijmegen MC
MTA 138
PO Box 9101
Nijmegen
6500 HB
Netherlands

Phone +31 (0)24 3610592
Email p.stalmeier@mta.umcn.nl

Study information

Primary study designInterventional
Study designNon randomised controlled trial
Secondary study designNon randomised controlled trial
Scientific title
Study objectivesHow many and which patients want to choose their own radiation dose?
Ethics approval(s)Ethics committee CWOM number 0012-0284. Ethics approval date 16 March 2001.
Health condition(s) or problem(s) studiedProstate cancer
InterventionControl group is usual care (150 patients). Intervention group is usual care plus decision aid (150 patients).
Intervention typeOther
Primary outcome measure(s)

Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation.

Key secondary outcome measure(s)

1. Substitute preferences of physicians
2. Quality of life measures
3. Decision evaluation measures
4. Coping measures
5. Knowledge measures
6. Treatment preferences

Completion date31/12/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexMale
Target sample size at registration300
Key inclusion criteriaPatients with prostate cancer referred for radiotherapy with curative intent are eligible.
Key exclusion criteriaLabile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language.
Date of first enrolment01/01/2001
Date of final enrolment31/12/2006

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Radboud University Nijmegen MC
Nijmegen
6500 HB
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 20/07/2007 Yes No